Proteins are synthesized by the ribosome and generally must fold to become functionally active. Although it is commonly assumed that the ribosome affects the folding process, this idea has been extremely difficult to demonstrate. We have developed an experimental system to investigate the folding of single ribosome-bound stalled nascent polypeptides with optical tweezers. In T4 lysozyme, synthesized in a reconstituted in vitro translation system, the ribosome slows the formation of stable tertiary interactions and the attainment of the native state relative to the free protein. Incomplete T4 lysozyme polypeptides misfold and aggregate when free in solution, but they remain folding-competent near the ribosomal surface. Altogether, our results suggest that the ribosome not only decodes the genetic information and synthesizes polypeptides, but also promotes efficient de novo attainment of the native state.
P roteins can spontaneously fold into their native structures under appropriate conditions (1) . In vitro, some small proteins and single domains attain their native structures within microseconds (2) , whereas topologically complex and larger proteins may require many seconds to fold (3) and often populate folding intermediates along the way (4, 5) . In vivo, however, folding is not necessarily limited to fulllength proteins or domains. Proteins can begin to fold before they are fully synthesized and while still bound to the ribosome (6) (7) (8) (9) (10) (11) (12) . Moreover, during protein synthesis on the ribosome (13) , elongation rates are regulated by factors including tRNA abundance (14) , codon order (15) , and mRNA secondary structure (16) . Decreasing these rates locally (17, 18) or globally (19) can affect the folding efficiency of newly synthesized proteins. The complete synthesis of even small proteins (100 amino acids or less) requires at least several seconds at a maximum rate of~20 amino acids per second in Escherichia coli (20) , giving nascent-chain segments sufficient time to conformationally equilibrate in the environment of the ribosome, perhaps adopting structures that are distinctly different from the native protein fold (7, 21) . However, the observation of folding transitions in ribosome-bound nascent proteins has not been possible, and a detailed analysis has been limited to computational approaches (22, 23) .
We have developed an experimental system to directly probe the folding of single ribosomebound nascent chains (24, 25) by subjecting them to force using optical tweezers ( Fig. 1 and figs. S1 to S3). The force is applied between the nascent chain and the large ribosomal subunit. Because force acts locally (26, 27) , we can selectively perturb the stability of ribosome-bound nascent polypeptides without disrupting the structural integrity of the ribosome. We studied a cysteine-free version of T4 lysozyme (28), a monomeric cytosolic protein composed of two globular regions, or subdomains (Fig. 1, C and D) . T4 lysozyme folding has been studied in ensemble (29) (30) (31) and single-molecule (27) experiments. The native fold requires interactions between the N-and C-terminal sequences whose synthesis is separated in time during vectorial translation by the ribosome.
Using a reconstituted in vitro translation system supplemented with E. coli ribosomes (32), we first translated the protein with an unstructured C-terminal extension of 41 amino acids such that the entire T4 lysozyme sequence emerges from the narrow ribosomal exit tunnel (33) . This experimental design allows us to study the folding dynamics of the full-length protein on the ribosome. When we stretched the molecule by continuously increasing the tension applied across the nascent chain ("force ramp"), we observed single rips in the resulting force-extension traces, representing cooperative unfolding events (Fig.  1E ). Puromycin-release experiments confirmed that these signals originated from ribosome-bound nascent proteins ( fig. S4) .
The mechanical unfolding pathways of free and ribosome-bound full-length T4 lysozyme are very similar: The latter unfolds at a mean force (F Unf ) of 17.0 T 2.0 pN (N = 125 unfolding events) at a pulling speed of 100 nm/s (Fig. 1G) . Using the wormlike chain (WLC) model (34), we calculated a contour length increase upon unfolding (∆ L C ) of 59.9 T 2.1 nm, consistent with the value expected for full-length T4 lysozyme (164 amino acids × 0.36 nm per amino acid -0.9 nm corresponding to the folded end-to-end distance = 58.1 nm). Experiments with the free protein in the absence of the ribosome (Fig. 1, F and H) revealed similar unfolding characteristics (F Unf = 17.2 T 1.8 pN, D L C = 60.1 T 0.9 nm, N = 453), confirming that the entire protein is able to emerge from the ribosomal tunnel by means of the 41-amino acid linker (33) . Analysis of the unfolding force distributions (35) of free and ribosomebound polypeptides (Fig. 1 , G and H) also reveals similar distances to the transition state (∆ ‡ x free = 2.3 T 0.5 nm, ∆x ‡ ribosome-bound = 2.0 T 0.2 nm) and native-state lifetimes ( fig. S5) . Thus, the ribosome-bound protein folds to the same native structure as the free protein and unfolds through the same pathway in the pulling experiments.
Whereas the unfolding transitions of free and ribosome-bound T4 lysozyme are indistinguishable in our experiments, the refolding exhibits marked differences: During repeated cycles of pulling and relaxation, the free protein virtually always refolds, but the ribosome-bound protein refolds only 28% of the time and lacks a welldefined refolding transition in the force-ramp measurements ( fig. S6 ). We carried out "forceclamp" experiments ( fig. S7 ) to better resolve the folding transition. From measurements of the refolding time, t refold ( Fig. 2A) , we estimated apparent refolding rates at 3.6 pN (Fig. 2B) ), more than two orders of magnitude slower than the free protein.
The 41-amino acid linker is long enough to allow the entire protein to emerge from the exit tunnel but restricts the folding environment to the immediate vicinity of the ribosomal polypeptide exit site. ) (Fig. 2B ), significantly faster than the rate observed with the shorter linker, but still more slowly than the free protein (Fig.  2B , also compare Fig. 2C with 2A) . We used this construct to characterize the folding of the ribosome-bound protein in more detail.
Given the high negative charge density of the ribosomal RNA (rRNA) moiety, the observed deceleration in folding is likely mediated by electrostatic interactions of the ribosomal surface with charged residues in the nascent chain (36) . Increasing the potassium chloride concentration from 150 to 500 mM, which results in more effective screening of electrostatic interactions (32) , increased the folding rate of the ribosome-bound protein, whereas the folding rates of the free protein were less sensitive to salt (Fig. 2D) . Thus, the effect of the ribosome on the folding of the nascent polypeptide is mediated, at least in part, by electrostatic interactions.
Close inspection of the force clamp traces revealed that, before folding to the native state (N), the protein transiently and reversibly samples an intermediate (I) from the unfolded state (U) (Fig.  2 , A and C), exhibiting bistability, or "hopping."
In almost all traces examined, folding to the native state then proceeds from the intermediate state ( Fig. 2A, arrowhead) , indicating that the latter is an on-pathway state and, therefore, obligatory for productive attainment of the native state. The I-to-N transition is practically irreversible at the refolding force; thus, the folding pathway can be written as
From the extension changes in the forceclamp traces, we estimate that between 96 and 108 residues participate in the formation of the folding intermediate. These dimensions are consistent with a folding intermediate that is formed largely by the C-terminal T4 lysozyme subdomain (32) and might be related to a previously described "hidden intermediate" (37) .
The probability of occupying the state I (relative to U ) during hopping ( fig. S8 ) is similar in the presence and absence of the ribosome (Fig. 2E) . From the force at which U and I are equally populated (F 1/2 ≈ 3.6 pN) and the observed change in extension between U and I at that force (∆x U-I ≈ 10 nm), we estimate that I is stabilized by a Gibbs free energy of unfolding [ (32) .
To explore the ribosomal effect within the folding pathway, we used a Bayesian Hidden Markov model (BHMM) approach to conduct a kinetic analysis of the force-clamp data (Fig. 3A ) (32) . The values for the rates of the U-to-I and I-to-U transitions (k U-I and k I-U , respectively) are essentially the same for the free and the ribosome-bound protein (60-amino acid linker). In contrast, k I-N of the ribosome-bound protein is smaller by at least one order of magnitude com- (Fig. 3A) . The BHMM analysis also yields estimates of the extensions of each species (fig. S9) . Interestingly, the unfolded protein, both free and ribosomebound, is more compact than predicted from a WLC model (34) at forces below 4 pN (Fig. 3B) . This deviation from the model is consistent with a compaction of the unfolded protein, perhaps reflecting transient local secondary structure formation at those low forces before cooperative folding transitions. For the free protein, the unfolded-state extensions gradually increase to the values predicted by the WLC model when the force is raised to 5 pN. Notably, the unfolded state remains more compact in the ribosomebound protein (over the limited force range accessible in these measurements; Fig. 3B) . Thus, the ribosomal interactions appear to have a dual effect: deceleration of native tertiary-structure formation and stabilization of a compacted state before folding (Fig. 3C) , presumably mediated at least in part by electrostatic interactions.
REPORTS
How might the ribosome contribute to efficient de novo protein folding? So far, we have described folding of the entire protein. To study folding before completion of synthesis, we translated the N-terminal 149 amino acids of T4 lysozyme, so that~110 to 120 residues of the full T4 lysozyme sequence (164 residues) exited the ribosome (~70% of the full protein), whereas 30 to 40 amino acids remained within the exit tunnel. Upon stretching the ribosome-bound polypeptide, the force-extension curves did not reveal any cooperative folding or unfolding transitions ( fig. S10 ). Even when we extended the T4 lysozyme sequence by a 20-amino acid linker (so that~144 to 154 out of the 164 amino acids of T4 lysozyme are outside the tunnel), we did not detect folding (Fig. 4A) , presumably because the C-terminal residues, which interact with the Nterminal A helix in the native structure, are still sequestered within the ribosomal exit tunnel.
Attempts to express soluble fragments in E. coli were unsuccessful ( fig. S11) . Thus, we used puromycin-modified DNA oligonucleotides (39) to release the in vitro translated 149-amino acid fragment from the ribosome (32) . In contrast to the lack of transitions observed on the ribosome, the released fragment unfolded at a range of forces and contour length changes (Fig. 4B) , indicating that it adopts a highly heterogeneous ensemble of structures, some of which exhibit considerable (mechanical) stability. Given the homogeneous unfolding of the complete protein, it is unlikely that all of these structures represent productive, on-pathway species. Rather, the diverse behavior of this fragment is probably due to misfolding, aggregation, entanglement of several polypeptides immobilized in close vicinity, or interactions of the misfolded protein with the bead surface, none of which are observed for the ribosome-bound nascent protein. Thus, the ribosome appears to prevent misfolding of the incomplete protein through a kinetic mechanism, effectively acting as a molecular chaperone for nascent polypeptides. This chaperone activity is probably mediated by the surface surrounding the polypeptide exit tunnel and is distinct from the previously described "protein folding activity of the ribosome" mediated by the 26S rRNA (40) . Mechanisms that keep proteins in a folding-competent conformation may be particularly important if C-terminal residues, which are synthesized last, are required for productive folding, as in T4 lysozyme and other proteins (21, (41) (42) (43) .
In the cell, molecular chaperones interact with nascent polypeptides during their synthesis (44) . The in vitro experiments described here suggest that the ribosome contributes to efficient de novo folding in several ways. Polypeptide compaction, an early event during protein folding (45) , is promoted by the ribosome and may, in conjunction with the spatial arrangement within polysomes (46) , limit aberrant interactions among nascent chains. Rather than acting as an inert "wall," which would be expected to increase folding rates entropically (47, 48) , the ribosome slows folding of T4 lysozyme, presumably by attracting positively charged residues and repelling negatively charged ones within the same nascent polypeptide chain. Thus, it can bias the conformational search of the protein and its folding rate. This mechanism may complement the mode of action of other molecular chaperones that bind their substrates through hydrophobic interactions and may be particularly pronounced for T4 lysozyme and other basic proteins that represent a large group in most proteomes (49) . However, such a mechanism should be operative even for proteins harboring a net negative charge and may apply at least to cytosolic proteins, which are held in close proximity to the ribosomal surface during synthesis. Our findings may represent a paradigm for how the ribosome can, in principle, affect nascentchain folding. The system is easily adaptable for investigating proteins other than T4 lysozyme and should be amenable to observing nascentchain elongation in real time. These future experiments will shed more light onto how protein folding is tuned to synthesis. T he blood-brain barrier (BBB) confers homeostasis to the central nervous system (CNS) and limits the entry of blood-borne molecules and circulating leukocytes. The BBB is composed of specialized endothelial cells (ECs) held together by multiprotein complexes known as junctional proteins (1, 2) . Astrocytes, which are closely apposed to the CNS vasculature, help maintain BBB integrity and immune quiescence through contact-dependent mechanisms and by releasing soluble factors (2) (3) (4) (5) . BBB disruption is a central and early feature of multiple sclerosis (MS) that allows leukocytes to enter the CNS, leading to demyelination and neuronal damage (6) (7) (8) .
The Hedgehog (Hh) pathway is involved in embryonic morphogenesis, neuronal guidance, and angiogenesis (9, 10) . In adult tissues, it participates in vascular proliferation, differentiation, and tissue repair (11) (12) (13) . CNS morphogenic events are primarily associated with Sonic Hh (Shh) signaling (14) (15) (16) . Secreted Shh binds and inactivates the receptor Patched-1 (Ptch-1), allowing activation of Smoothened (Smo), which then induces target genes through the Gli family of transcription factors (17) . Previous studies have implicated Shh signaling in MS and its animal model (18, 19) . We therefore explored whether the Hh pathway contributes to the maintenance of BBB functions, including its immune quiescence.
mRNA and protein analyses demonstrated expression of Shh and its 45-kD uncleaved precursor in human fetal astrocytes (HFAs) but not on primary cultures of BBB ECs ( fig. S1, A and B) . In contrast, the highest levels of Ptch-1 and Smo expression were observed in BBB ECs ( fig. S1,  A and B) . Essential to Hh signaling is the autocatalytic cleavage of the 45-kD Shh protein to yield a~19-kD active form, which was present in astrocyte-conditioned media (ACM) (fig. S1B ). We detected Shh in human and mouse astrocytes in vitro and in situ but not in ECs or pericytes ( fig. S1, C to H) . Conversely, Ptch-1 and Smo were detected on cultured BBB ECs and in situ in human and mouse CNS ECs, but not on astrocytes or pericytes ( fig. S1, C to H) . Therefore, our data suggest that the Hh pathway is used by perivascular astrocytes to communicate with BBB ECs.
To determine whether astrocyte-secreted Shh influences BBB function, the transendothelial electrical resistance (TEER) and permeability of human BBB ECs were evaluated under conditions stimulating or abrogating the Hh pathway. We found that human recombinant Shh (hrShh) significantly increased TEER and decreased dextran 3-kD clearance, as well as permeability to 14 C-sucrose and bovine serum albumin-fluorescein isothiocyanate (BSA-FITC) (Fig. 1, A to D) . This effect was comparable to the one induced by ACM, and the response of BBB ECs to Shh did not affect EC proliferation ( fig. S2A) . Activation of the Hh pathway was responsible for the barrierpromoting effect of ACM, because BBB ECs treated with the Smo agonist purmorphamine reproduced the effect of hrShh, whereas Smo antagonists cyclopamine (Fig. 1, A to D) and SANT-1 ( fig. S2B ) reversed the effect of ACM. These data reflect a combination of changes in TEER, paracellular permeability, and inducible transport mechanisms, suggesting that Hh ligands could affect both processes, possibly through the regulation of junctional proteins.
Hh activation is associated with a restrictive permeability, therefore we determined the expression of the transcription factors Gli-1 and sex-determining region Y-box-18 (SOX-18), an important regulator of junctional protein expression (i.e., claudin-5) and barrier formation (20) . The number of BBB ECs expressing Gli-1 increased upon Hh activation, as compared to untreated cells. However, cyclopamine reduced the expression of Gli-1 induced by ACM (Fig. 1, E  and F) . hrShh stimulation and ACM significantly up-regulated Hip, Gli-1, and SOX-18 transcription ( Fig. 1G and fig. S2C ). SOX-18 expression was maximal 2 hours after Gli-1 activation, confirming that SOX-18 is regulated by the Hh pathway, possibly through Gli-1.
To further confirm the role of the Hh pathway in maintaining BBB properties in vivo, we injected mice with cyclopamine and studied the extent of BBB leakage. Cyclopamine induced acute BBB disruption (6 hours after injection), as demonstrated by the increased extravasation of exogenous dextran and endogenous fibrinogen (Fig. 1, H and I) . Cyclopamine treatment also
